Internal Medicine, Cardiovascular Disease · Wichita, KS
NPI
1376500785
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3535 N Webb Rd
Wichita, KS, 67226
Phone (316) 686-5300
Groups this clinician bills Medicare through
Medicare paid, 2024
$761K
11,386 services
Medicare patients, 2024
1,845
Average age 76
Drug cost, 2024
$1.4M
10,748 prescriptions
Company payments, 2025
$542
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Husam Bakdash was code 99214 (office e&m - established), 3,450 times for 1,389 patients. In total Husam Bakdash billed 11,386 services in 70 codes, and Medicare paid $761K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 3,450 | 1,389 | $82.54 | $285K |
| 93000 Electrocardiogram | Office | 1,907 | 1,277 | $8.91 | $17K |
| 93793 Care Management/Coordination | Office | 506 | 12 | $7.85 | $3,971 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 472 | 118 | $4.76 | $2,244 |
| 93296 External Electrocardiographic Monitoring | Office | 472 | 157 | $14.66 | $6,917 |
| 93298 External Electrocardiographic Monitoring | Office | 416 | 57 | $69.28 | $29K |
| 93306 Echocardiography (TTE/TEE) | Office | 379 | 368 | $127.21 | $48K |
| 93280 External Electrocardiographic Monitoring | Office | 325 | 112 | $24.89 | $8,090 |
| 93294 External Electrocardiographic Monitoring | Office | 322 | 113 | $21.13 | $6,803 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 293 | 147 | $86.64 | $25K |
| 99213 Office E&M - Established | Office | 255 | 210 | $55.15 | $14K |
| 93015 Electrocardiogram | Office | 235 | 233 | $44.02 | $10K |
| 85610 Clinical Chemistry | Office | 228 | 18 | $4.20 | $958 |
| 93306 Echocardiography (TTE/TEE) | Facility | 209 | 203 | $46.81 | $9,783 |
| 93295 External Electrocardiographic Monitoring | Office | 154 | 47 | $26.19 | $4,033 |
By year: 2022 $765K for 12,622 services; 2023 $748K for 12,358 services; 2024 $761K for 11,386 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 228 | 18 | $4.20 | $958 |
Medicare prescription drug claims, 2024
In 2024, the drug Husam Bakdash prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,134 prescriptions and refills. In total Husam Bakdash wrote 10,748 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,134 | 1,672 | 193 | $962K |
| Atorvastatin Calcium Generic | 1,051 | 2,363 | 245 | $5,132 |
| Lisinopril Generic | 948 | 1,995 | 206 | $2,936 |
| Metoprolol Succinate Generic | 854 | 1,896 | 214 | $6,570 |
| Furosemide Generic | 797 | 1,439 | 190 | $2,674 |
| Amlodipine Besylate Generic | 654 | 1,401 | 149 | $2,469 |
| Carvedilol Generic | 530 | 1,242 | 133 | $2,154 |
| Metoprolol Tartrate Generic | 488 | 1,247 | 134 | $2,042 |
| Clopidogrel Clopidogrel Bisulfate | 363 | 778 | 89 | $2,205 |
| Losartan Potassium Generic | 333 | 800 | 90 | $1,828 |
| Sotalol Sotalol Hcl | 294 | 646 | 74 | $4,454 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 270 | 510 | 56 | $5,503 |
| Hydrochlorothiazide Generic | 265 | 566 | 68 | $930 |
| Potassium Chloride Generic | 254 | 485 | 66 | $5,461 |
| Amiodarone Hcl Generic | 170 | 335 | 55 | $1,565 |
Brand drugs: 1,721 claims; generic drugs: 9,027 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Husam Bakdash $542 ($542 in general payments such as food, travel and fees) from 7 companies. The largest payer was Medtronic, Inc. with $173.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.